Global Liquid Biopsy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2016 to 2022

  • ID: 4313272
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Biocept
  • Foundation Medicine
  • Genomic Health
  • Myriad Genetics
  • Natera
  • Oncocyte
  • MORE
Liquid Biopsy Market Growth, Future Prospects and Competitive Analysis, 2016-2022, the liquid biopsy market was valued at USD 1,881.9 Mn in 2015, and is expected to reach USD 10,850.3 Mn by 2022, expanding at a CAGR of 24.7% from 2016 to 2022.

Market Insights
In the past, tissue samples extracted through biopsy were evaluated to detected malignancy. However, some micrographs delivered inconsistent and ambiguous results, thus demanding repeated procedure. The advent of molecular diagnostics and next generation sequencing offered pathologists with a powerful tool for efficient diagnosis. Even with such advances, cancer diagnosis still remained subject to the limitation of availability of biopsied tissue, which further posed a challenge in case of monitoring therapy success monitoring. The eventual advent of liquid biopsy however, overcame this constraint by efficiently employing precise circulating tumor cells (CTCs) detection and isolation.

In the recent period, the range of liquid biopsy tools has expanded to incorporation of circulating tumor DNA (ctDNA) and extracellular vesicles (EVs). ctDNA contains a small fraction of the patient's cell free DNA; it can be readily evaluated for genetic inconsistency using target amplification and sequencing tools. In addition, EVs is currently the latest addition to liquid biopsy portfolio. EVs provide easy access to biomolecule subsets present in whole cells. EVs based technology is focused on identifying mutations in mRNA.

Extensive research is being taken place in the recent years on creating sophisticated analytical tools for analysis of cancer cells for detecting genetic variation at low allele frequency. CTCs are first of such units of liquid biopsy. However, advent of easy isolation of cell-free DNA has provided vital insights that move a step ahead to that of CTCs. The latest tools of EVs analysis are rapidly gaining importance on the basis of their potential ability of identifying genetic variation. The latest CTC technologies employ EpCAM protein for immunocapture, however this tool demonstrate reduced expression during epithelial to mesenchymal transition. Other isolation techniques are heavily dependent on cell size, cellular behavior in electric fields, morphology and deformability. Scarcity of CTCs in blood has urged researchers to develop evolved methods for obtaining molecular information from single cells, thus increasing their potential use in therapy monitoring.
As the commercial interest in this field is on the rise, several large diagnostics and medical technologies companies have ventured in this market. Moreover, there is also a significant rise in the number of startups specializing in the field. Industry giants are striking deals with pharma and biotech companies to expand application areas of liquid biopsy.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Biocept
  • Foundation Medicine
  • Genomic Health
  • Myriad Genetics
  • Natera
  • Oncocyte
  • MORE
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Liquid Biopsy Market Share, by Analytes, 2015 (Value %)
2.2 Liquid Biopsy Market, by Applications, 2015 (USD Mn)
2.3 Liquid Biopsy Market Share, by Geography, 2015 (Value %)

Chapter 3 Liquid Biopsy Market: Market Dynamics and Outlook
3.1 Introduction
3.2 Major Commercial Events
3.3 Major Research Events
3.4 Drivers
3.5 Challenges
3.6 Future Prospects
3.7 Attractive Investment Proposition
3.1 Competitive Analysis: Fractal Map Investigation, by Key Market Players

Chapter 4 Global Liquid Biopsy Market Analysis, by Analytes
4.1 Preface
4.2 Circulating Tumor Cells (Ctcs)
4.3 Circulating Tumor Dna (Ctdna)
4.4 Extracellular Vesicles (Evs)

Chapter 5 Global Liquid Biopsy Market Analysis, by Application
5.1 Preface
5.2 Prognosis
5.3 Diagnosis
5.4 Therapy Monitoring
5.5 Others

Chapter 6 Global Liquid Biopsy Market, by Geography
6.1 Preface
6.2 North America
6.2.1 U.S
6.2.2 Canada
6.3 Europe
6.3.1 U.K
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia-Pacific
6.4.1 Japan
6.4.2 China
6.4.3 Rest of Asia-Pacific
6.5 Middle East and Africa (Mea)
6.6 Latin America

Chapter 7 Company Profiles
7.1 Myriad Genetics
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Positions/Portfolio
7.1.4 News Coverage
7.2 Oncocyte
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Positions/Portfolio
7.2.4 News Coverage
7.3 Raindance Technologies
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Positions/Portfolio
7.3.4 News Coverage
7.4 Veracyte
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Positions/Portfolio
7.4.4 News Coverage
7.5 Foundation Medicine
7.5.1 Business Description
7.5.2 Financial Health and Budget Allocation
7.5.3 Product Positions/Portfolio
7.5.4 News Coverage
7.6 Genomic Health
7.6.1 Business Description
7.6.2 Financial Health and Budget Allocation
7.6.3 Product Positions/Portfolio
7.6.4 News Coverage
7.7 Biocept
7.7.1 Business Description
7.7.2 Financial Health and Budget Allocation
7.7.3 Product Positions/Portfolio
7.7.4 News Coverage
7.8 Natera
7.8.1 Business Description
7.8.2 Financial Health and Budget Allocation
7.8.3 Product Positions/Portfolio
7.8.4 News Coverage
7.9 Qiagen
7.9.1 Business Description
7.9.2 Financial Health and Budget Allocation
7.9.3 Product Positions/Portfolio
7.9.4 News Coverage
7.10 Trovagene
7.10.1 Business Description
7.10.2 Financial Health and Budget Allocation
7.10.3 Product Positions/Portfolio
7.10.4 News Coverage
7.11 Others
7.11.1 Business Description
7.11.2 Financial Health and Budget Allocation
7.11.3 Product Positions/Portfolio
7.11.4 News Coverage

List of Figures
Figure 1 Liquid Biopsy: Market Segmentation
Figure 2 Liquid Biopsy Market Share, by Analytes, 2015 (Value %)
Figure 3 Liquid Biopsy Market, by Analytes, 2015 (USD Mn)
Figure 4 Liquid Biopsy Market Share, by Geography, 2015 (Value %)
Figure 5 Attractive Investment Proposition, Liquid Biopsy Market, 2015
Figure 6 Competitive Analysis: Fractal Map Investigation, by Key Market Players
Figure 7 Global Ctc Based Liquid Biopsy Market, 2014 - 2022 (USD Mn)
Figure 8 Global Ctdna Based Liquid Biopsy Market, 2014 - 2022 (USD Mn)
Figure 9 Global Extracellular Vesicles Based Liquid Biopsy Market, 2014 - 2022 (USD Mn)
Figure 10 Global Liquid Biopsy for Disease Prognosis Market, 2014 - 2022 (USD Mn)
Figure 11 Global Liquid Biopsy for Disease Diagnosis Market, 2014 - 2022 (USD Mn)
Figure 12 Global Liquid Biopsy for Therapy Monitoring Market, 2014 - 2022 (USD Mn)
Figure 13 Global Liquid Biopsy for Other Applications Market, 2014 - 2022 (USD Mn)
Figure 14 U.S. Liquid Biopsy Market, 2014 - 2022 (USD Mn)
Figure 15 Canada Liquid Biopsy Market, 2014 - 2022 (USD Mn)
Figure 16 U.K. Liquid Biopsy Market, 2014 - 2022 (USD Mn)
Figure 17 Germany Liquid Biopsy Market, 2014 - 2022 (USD Mn)
Figure 18 Rest of Europe Liquid Biopsy Market, 2014 - 2022 (USD Mn)
Figure 19 Japan Liquid Biopsy Market, 2014 - 2022 (USD Mn)
Figure 20 China Liquid Biopsy Market, 2014 - 2022 (USD Mn)
Figure 21 Rest of Asia-Pacific Liquid Biopsy Market, 2014 - 2022 (USD Mn)
Figure 22 Middle East and Africa Liquid Biopsy Market, 2014 - 2022 (USD Mn)
Figure 23 Latin America Liquid Biopsy Market, 2014 - 2022 (USD Mn)

List of Tables
Table 1 Global Liquid Biopsy Market, by Components, 2014 - 2022 (USD Mn)
Table 2 Global Liquid Biopsy Market, by Application, 2014 - 2022 (USD Mn)
Table 3 Global Liquid Biopsy Market, by Geography, 2014 - 2022 (USD Mn)
Table 4 North America Liquid Biopsy Market, by Country, 2014 - 2022 (USD Mn)
Table 5 Europe Liquid Biopsy Market, by Country, 2014 - 2022 (USD Mn)
Table 6 Asia-Pacific Liquid Biopsy Market, by Country, 2014 - 2022 (USD Mn)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Myriad Genetics
  • Oncocyte
  • RainDance Technologies
  • Veracyte
  • Foundation Medicine
  • Genomic Health
  • Biocept
  • Natera
  • Qiagen
  • Trovagene
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll